The stock of Tiziana Life Sciences Ltd (NASDAQ: TLSA) has increased by 13.15 when compared to last closing price of 0.67.Despite this, the company has seen a gain of 50.75% in its stock price over the last five trading days. Proactive Investors reported 2024-04-22 that Tiziana Life Sciences Ltd (NASDAQ:TLSA) has unveiled additional positive results from its Expanded Access Program for patients with non-active secondary progressive multiple sclerosis (na-SPMS). The clinical-stage biopharmaceutical company said patients treated with its investigative therapeutic intranasal foralumab demonstrated multiple improvements, with 70% showing an improvement in fatigue after six months of follow-up.
Is It Worth Investing in Tiziana Life Sciences Ltd (NASDAQ: TLSA) Right Now?
The stock has a 36-month beta value of 0.57. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TLSA is 120.59M, and at present, short sellers hold a 0.27% of that float. On April 23, 2024, the average trading volume of TLSA was 100.97K shares.
TLSA’s Market Performance
The stock of Tiziana Life Sciences Ltd (TLSA) has seen a 50.75% increase in the past week, with a 62.41% rise in the past month, and a 27.73% gain in the past quarter. The volatility ratio for the week is 28.44%, and the volatility levels for the past 30 days are at 14.23% for TLSA. The simple moving average for the past 20 days is 58.11% for TLSA’s stock, with a 24.55% simple moving average for the past 200 days.
Analysts’ Opinion of TLSA
Many brokerage firms have already submitted their reports for TLSA stocks, with B. Riley Securities repeating the rating for TLSA by listing it as a “Buy.” The predicted price for TLSA in the upcoming period, according to B. Riley Securities is $8 based on the research report published on December 22, 2020 of the previous year 2020.
TLSA Trading at 52.96% from the 50-Day Moving Average
After a stumble in the market that brought TLSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.66% of loss for the given period.
Volatility was left at 14.23%, however, over the last 30 days, the volatility rate increased by 28.44%, as shares surge +62.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +43.82% upper at present.
During the last 5 trading sessions, TLSA rose by +50.75%, which changed the moving average for the period of 200-days by +13.14% in comparison to the 20-day moving average, which settled at $0.4911. In addition, Tiziana Life Sciences Ltd saw 34.57% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for TLSA
The total capital return value is set at -0.74.
Based on Tiziana Life Sciences Ltd (TLSA), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -21.82. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is -1434.29.
Currently, EBITDA for the company is -15.34 million with net debt to EBITDA at 0.62.
Conclusion
To sum up, Tiziana Life Sciences Ltd (TLSA) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
